Ming-Chi Kuo: iPhone 14 Pro Models to Have A16 Bionic Chip Based on Existing 5nm Process Tech
Reputable analyst Ming-Chi Kuo has tweeted that the A16 Bionic chip will be based on the N5P logic node that was previously used to manufacture the A15 Bionic chip, citing TSMC roadmap and public announcements. According to the analyst, Apple will continue to refer to the new processor as the A16 Bionic for marketing purposes.
However, Kuo did say that the A16 could have slight performance and power-saving improvements over the current A15 Bonic.
While the A16 Bionic chip would be used in the iPhone 14 Pro and iPhone 14 Pro Max, Kuo previously speculated that the iPhone 14 models would use the same A15 SoC as the iPhone 13 series.
Apple would not be able to deliver significant chip-level performance differences between the iPhone 14 and iPhone 14 Pro models, according to the analyst's latest comments, because both would use chips based on the same 5nm process technology. Nonetheless, the company has a track record of improving user experiences through software refinement.
Kuo also claimed that, like the iPhone 14 Pro models, the new MacBook Air models would continue to use the same CPU architecture found on the M1 chip, which is also found on the A15 Bionic SoC.
According to previous reports, Apple will use the M2 chip in its new MacBook Air models. While the M2 series, which offers a significant performance boost over the M1 chip, is expected to appear on the next 14- or 16-inch MacBook Pro model, Kuo believes that the Cupertino company may eventually introduce a new MacBook Air with an M2 CPU to boost its marketing.
The fact that TSMC is not expected to bring the N3 and N4P logic nodes for mass production until 2023 is the primary reason for predicting that Apple will not bring any noticeable performance upgrades this time. The company has the N5P and N4 technologies, which have no significant differences between them. As a result, Apple's decision to stick with the N5P process makes sense.